Zimmer Biomet Holdings Stock News

Healthcare Education Solutions Market 2021 Over the forecast period, the global Healthcare Education Solutions market research study predicts revenue growth. It investigates the various market stakeholders, such as manufacturers, vendors, and end users. The research also considers the industry''s potential. To

A market study Global Patella Prosthesis Market examines the performance of the Patella Prosthesis market 2022. It encloses an in-depth analysis of the Patella Prosthesis market state and the competitive landscape globally. Patella Prosthesis report analyzes the prospect of Patella

Analysts expect Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to report earnings per share (EPS) of $1.97 for the current quarter, according to Zacks Investment Research. Nine analysts have issued estimates for Zimmer Biomets earnings. The lowest EPS estimate is $1.93 and the highest is $1.99. Zimmer Biomet reported earnings per share of $2.11 in the same []

The Laboratory Equipment Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Laboratory Equipment Market report is to supply an in-depth view

The Asia Pacific Metal Trauma Implant Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Asia Pacific Metal Trauma Implant Market report

The Global Bone Grafts and Substitutes Market size valued USD 2.96 billion in 2019, and is predicted to reach USD 4.85 billion by 2030, witnessing a CAGR of 4.5% from 2020-2030. Bone grafting is a surgical procedure to operate extremely complicated

Needham & Company LLC downgraded shares of Zimmer Biomet (NYSE:ZBH) from a strong-buy rating to a buy rating in a research note published on Thursday morning, PriceTargets.com reports. The firm currently has $158.00 price objective on the medical equipment providers stock, down from their prior price objective of $175.00. Several other research firms have also []

Cubic Asset Management LLC increased its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 8.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,970 shares of the medical equipment providers stock after buying an additional 680 shares during the period. Cubic []

Kestra Private Wealth Services LLC raised its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 4.3% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,897 shares of the medical equipment providers stock after acquiring an additional 204 shares during the []

Zimmer Biomet (NYSE:ZBH) was downgraded by stock analysts at Needham & Company LLC from a strong-buy rating to a buy rating in a report released on Thursday, PriceTargets.com reports. They currently have a $158.00 target price on the medical equipment providers stock, down from their previous target price of $175.00. Needham & Company LLCs target [] The post Zimmer Biomet (NYSE:ZBH) Downgraded by Needham & Company LLC appeared first on ETF Daily News .

Campbell Wealth Management bought a new stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,372 shares of the medical equipment providers stock, valued at approximately $201,000. Several other institutional investors have also made changes to their positions []

Royal Bank of Canada assumed coverage on shares of Zimmer Biomet (NYSE:ZBH) in a research report sent to investors on Thursday morning, The Fly reports. The firm issued a sector perform rating on the medical equipment providers stock. A number of other equities analysts have also recently issued reports on ZBH. Deutsche Bank Aktiengesellschaft cut []

Related Stocks: CSGP , ZBH , EA , PINS , SGEN , NVST , HEI.A , CLVT , LEVI , SKYT , SQ , ZEN , GKOS , DLTR , TT , ZNGA , RMD ,

Loop Capital initiated coverage on shares of Zimmer Biomet (NYSE:ZBH) in a research note released on Monday morning, Price Targets.com reports. The brokerage issued a buy rating and a $165.00 price objective on the medical equipment providers stock. Several other equities research analysts have also recently issued reports on the stock. Citigroup reduced their price [] The post Zimmer Biomet (NYSE:ZBH) Earns Buy Rating from Analysts at Loop Capital appeared first on ETF Daily News .

Medical device companies are struggling with difficult economic conditions and a COVID-19 resurgence.